{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:16:21Z","timestamp":1753877781204,"version":"3.41.2"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Basic Application Research Project of Sichuan Science and Technology Department","award":["2022NSFSC0692"],"award-info":[{"award-number":["2022NSFSC0692"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To analyse the associations between renal function and clinical laboratory indicators and explore the renal function abnormality risk factors for gout patients in Southwest China.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Outpatient and hospitalized gout patients (n\u2009=\u20094384) at the First Affiliated Hospital of Chengdu Medical College between January 2017 and December 2020 were divided into normal (n\u2009=\u20092393) and abnormal (n\u2009=\u20091991) renal function groups according to their eGFR. The relationships between clinical laboratory indicators and the eGFR were analysed, and a logistic regression model was fit to identify significant risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sex, age, absolute lymphocyte count (ALC), cystatin C (CysC), homocysteine (Hcy) and thyroid stimulating hormone (TSH) were associated with renal function abnormalities (P\u2009&amp;lt;\u20090.05), whereas age [odds ratio (95% CI) = 1.06 (1.05\u20131.08), P\u2009&amp;lt;\u20090.001], Hcy [1.02 (1.00\u20131.04), P\u2009=\u20090.028], CysC [1.72 (1.54\u20131.92), P\u2009&amp;lt;\u20090.001], ALC [0.71 (0.52\u20130.97), P\u2009=\u20090.03] and TSH [1.08 (1.00\u20131.17), P\u2009=\u20090.049] were abnormal renal function risk factors for gout patients. After stratification by UA, binary logistic regression analysis identified the following risk factors: Q1 age [1.06 (1.02\u20131.11), P\u2009=\u20090.003], CysC [1.67 (1.30\u20132.16), P\u2009&amp;lt;\u20090.001]; Q2 age [1.09 (1.06\u20131.12), P\u2009&amp;lt;\u20090.001], CysC [1.55 (1.28\u20131.88), P\u2009&amp;lt;\u20090.001], FT3 [0.66 (0.46\u20130.96), P\u2009=\u20090.029]; Q3 age [1.06 (1.03\u20131.09), P\u2009&amp;lt;\u20090.001], CysC [1.75 (1.41\u20132.18), P\u2009&amp;lt;\u20090.001], Hcy [1.04 (1.00\u20131.08), P\u2009=\u20090.047], ALC [0.35 (0.18\u20130.69), P\u2009=\u20090.002]; Q4 age [1.05 (1.02\u20131.09), P\u2009=\u20090.004], CysC [1.79 (1.40\u20132.30), P\u2009&amp;lt;\u20090.001].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>ALC and levels of TSH and serum Cys could be used for monitoring for abnormal renal function in patients with gout.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rap\/rkae151","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:06:20Z","timestamp":1734717980000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of risk factors for abnormal renal function in patients with gout in Southwest China: a cross-sectional study"],"prefix":"10.1093","volume":"9","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College , Chengdu, Sichuan, PR","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Chengdu Medical College , Chengdu, Sichuan,","place":["PR China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[{"name":"Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College , Chengdu, Sichuan,","place":["PR China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wantai","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College , Chengdu, Sichuan, PR","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"2025030418595373600_rkae151-B1","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10067-020-05090-8","article-title":"Gout: a disease involved with complicated immunoinflammatory responses: a narrative review","volume":"39","author":"Wu","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025030418595373600_rkae151-B2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/art.40662","article-title":"The risk of gout among patients with sleep apnea: a matched cohort study","volume":"71","author":"Blagojevic-Bucknall","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025030418595373600_rkae151-B3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025030418595373600_rkae151-B4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.semarthrit.2012.09.009","article-title":"Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010","volume":"42","author":"Juraschek","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2025030418595373600_rkae151-B5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2215\/CJN.06790616","article-title":"The 3-year incidence of gout in elderly patients with CKD","volume":"12","author":"Tan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025030418595373600_rkae151-B6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2025030418595373600_rkae151-B7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40620-021-00985-4","article-title":"Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project","volume":"35","author":"Russo","year":"2022","journal-title":"J Nephrol"},{"key":"2025030418595373600_rkae151-B8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7861\/clinmed.cg.20.2","article-title":"Chronic kidney disease in adults: assessment and management","volume":"20","author":"Forbes","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"2025030418595373600_rkae151-B9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2025030418595373600_rkae151-B10","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025030418595373600_rkae151-B11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1056\/NEJMe2215286","article-title":"Chronic kidney disease\u2013another step forward","volume":"388","author":"August","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030418595373600_rkae151-B12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/s0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"2025030418595373600_rkae151-B13","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1056\/NEJMra2201153","article-title":"Uses of GFR and albuminuria level in acute and chronic kidney disease","volume":"386","author":"Levey","year":"2022","journal-title":"N Engl J Med"},{"key":"2025030418595373600_rkae151-B14","first-page":"35","article-title":"Correlation of eGFR by MDRD and CKD-EPI formula with creatinine clearance estimation in CKD patients and healthy subjects","volume":"30","author":"Das","year":"2021","journal-title":"Mymensingh Med J"},{"key":"2025030418595373600_rkae151-B15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2215\/cjn.06870909","article-title":"Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI formulas in relation to GFR, age, and body size","volume":"5","author":"Michels","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025030418595373600_rkae151-B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semarthrit.2015.02.004","article-title":"The economic burden of gout: a systematic review","volume":"45","author":"Rai","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2025030418595373600_rkae151-B17","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2025030418595373600_rkae151-B18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2025030418595373600_rkae151-B19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11906-020-01116-3","article-title":"Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection","volume":"22","author":"Kielstein","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"2025030418595373600_rkae151-B20","doi-asserted-by":"publisher","first-page":"105209","DOI":"10.1016\/j.phrs.2020.105209","article-title":"Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets","volume":"161","author":"Balakumar","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025030418595373600_rkae151-B21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41581-019-0174-z","article-title":"The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD","volume":"15","author":"Sato","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025030418595373600_rkae151-B22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10157-016-1288-2","article-title":"Time to target uric acid to retard CKD progression","volume":"21","author":"Kumagai","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"2025030418595373600_rkae151-B23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1681\/asn.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"Weiner","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2025030418595373600_rkae151-B24","doi-asserted-by":"publisher","first-page":"e1002725","DOI":"10.1371\/journal.pmed.1002725","article-title":"No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study","volume":"16","author":"Jordan","year":"2019","journal-title":"PLoS Med"},{"key":"2025030418595373600_rkae151-B25","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"key":"2025030418595373600_rkae151-B26","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N Engl J Med"},{"key":"2025030418595373600_rkae151-B27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2025030418595373600_rkae151-B28","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/s0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"2025030418595373600_rkae151-B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040867","article-title":"The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art","volume":"20","author":"Esse","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025030418595373600_rkae151-B30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40620-019-00618-x","article-title":"The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort","volume":"32","author":"Cohen","year":"2019","journal-title":"J Nephrol"},{"key":"2025030418595373600_rkae151-B31","doi-asserted-by":"publisher","first-page":"843534","DOI":"10.3389\/fnut.2022.843534","article-title":"Genetic evidence supporting the causal role of homocysteine in chronic kidney disease: a Mendelian randomization study","volume":"9","author":"Xiong","year":"2022","journal-title":"Front Nutr"},{"key":"2025030418595373600_rkae151-B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40620-013-0037-9","article-title":"Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population","volume":"27","author":"Chao","year":"2014","journal-title":"J Nephrol"},{"key":"2025030418595373600_rkae151-B33","doi-asserted-by":"publisher","first-page":"4252047","DOI":"10.1155\/2020\/4252047","article-title":"Nitrative stress-related autophagic insufficiency participates in hyperhomocysteinemia-induced renal aging","volume":"2020","author":"Zhang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"2025030418595373600_rkae151-B34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3346\/jkms.2014.29.6.788","article-title":"Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients","volume":"29","author":"Choi","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2025030418595373600_rkae151-B35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/annrheumdis-2012-202023","article-title":"Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout","volume":"72","author":"Slot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025030418595373600_rkae151-B36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.apsb.2015.08.001","article-title":"Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors","volume":"5","author":"Siklos","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"2025030418595373600_rkae151-B37","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200722","article-title":"Significance of serum markers and urinary microalbumin in the diagnosis of early renal damage in patients with gout","volume":"67","author":"Tang","year":"2021","journal-title":"Clin Lab"},{"key":"2025030418595373600_rkae151-B38","doi-asserted-by":"publisher","DOI":"10.3390\/biom13071075","article-title":"Should cystatin C eGFR become routine clinical practice?","volume":"13","author":"Spencer","year":"2023","journal-title":"Biomolecules"},{"key":"2025030418595373600_rkae151-B39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"key":"2025030418595373600_rkae151-B40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ekir.2017.10.012","article-title":"Cystatin C predicts renal recovery earlier than creatinine among patients with acute kidney injury","volume":"3","author":"Gharaibeh","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2025030418595373600_rkae151-B41","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"2025030418595373600_rkae151-B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/circulationaha.106.644286","article-title":"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"key":"2025030418595373600_rkae151-B43","doi-asserted-by":"publisher","first-page":"e48961","DOI":"10.7759\/cureus.48961","article-title":"Advances in thyroid function tests: precision diagnostics and clinical implications","volume":"15","author":"Yazdaan","year":"2023","journal-title":"Cureus"},{"key":"2025030418595373600_rkae151-B44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","article-title":"Hormone- and antibody-mediated activation of the thyrotropin receptor","volume":"609","author":"Duan","year":"2022","journal-title":"Nature"},{"key":"2025030418595373600_rkae151-B45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.maturitas.2013.03.009","article-title":"Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults","volume":"75","author":"Gopinath","year":"2013","journal-title":"Maturitas"},{"key":"2025030418595373600_rkae151-B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000497326","article-title":"Association of thyrotropin concentration with chronic kidney disease in a Japanese general population cohort","volume":"142","author":"Toda","year":"2019","journal-title":"Nephron"},{"key":"2025030418595373600_rkae151-B47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12882-023-03111-7","article-title":"Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study","volume":"24","author":"Kim","year":"2023","journal-title":"BMC Nephrol"},{"key":"2025030418595373600_rkae151-B48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3945\/ajcn.2008.27390","article-title":"Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease","volume":"90","author":"Kovesdy","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"2025030418595373600_rkae151-B49","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2215\/cjn.10521110","article-title":"Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease","volume":"6","author":"Agarwal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025030418595373600_rkae151-B50","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s11255-014-0687-0","article-title":"Relative lymphocyte count as a marker of progression of chronic kidney disease","volume":"46","author":"Kim","year":"2014","journal-title":"Int Urol Nephrol"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkae151\/61249403\/rkae151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/1\/rkae151\/61249403\/rkae151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/1\/rkae151\/61249403\/rkae151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:59:31Z","timestamp":1741121971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkae151\/7929821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkae151","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2024,12,18]]},"article-number":"rkae151"}}